SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-010427
Filing Date
2022-04-19
Accepted
2022-04-19 16:01:17
Documents
18
Period of Report
2022-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44657
2 ex1-1.htm EX-1.1 275593
3 ex4-1.htm EX-4.1 125160
4 ex5-1.htm EX-5.1 17675
5 ex99-1.htm EX-99.1 15904
6 ex99-2.htm EX-99.2 16559
7 ex5-1_002.jpg GRAPHIC 3480
  Complete submission text file 0001493152-22-010427.txt   777994

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ocx-20220413.xsd EX-101.SCH 3030
9 XBRL LABEL FILE ocx-20220413_lab.xml EX-101.LAB 34476
10 XBRL PRESENTATION FILE ocx-20220413_pre.xml EX-101.PRE 22594
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3467
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 22834961
SIC: 2835 In Vitro & In Vivo Diagnostic Substances